Resolvyx Pharmaceuticals

Resolvyx, founded in 2005, was a biopharmaceutical company dedicated to the discovery, development, and commercialization of resolvins, a novel class of therapies to treat inflammatory diseases and their complications. The company ceased operations in 2011.